Minister of Health and Consumer Affairs, Catalina GarciaReporting with Jorge del Diego, Director of the Public Health and Drug Regulatory Agency, next steps Respiratory syncytial virus (RSV) immunization begins September 25. RSV is a major cause of respiratory infections, e.g. Bronchiolitis or pneumonia.
Likewise, he reported that since Parents have started accepting appointments on Thursday the 14th vaccination Under six months.this The total contracted doses for the 2023-2024 campaign is 63,600 dosesthere is one Total budget 13.8 million euros.These doses will be given to all children born in October 1, 2023 to March 31, 2024.Likewise, it will also be managed Also applies to all babies born between April 1 and September 30, 2023will be captured at the end of this month.
Additionally, it will be Children under one year old who were born prematurely less than 35 weeksand others Infants under 24 months of age with very high-risk chronic conditions.
With this immunity Effectively and safely prevent infection For this virus, Respiratory condition This first happened in autumn and winter. In this sense, it is recommended that all parents with children under six months of age accept the invitation for RSV immunization. exactly, last yearinfection with this virus persists Andalusia welcomes 301 minors (during the largest peak in November).
“We firmly believe This is a relief for parents and families Logically, they are concerned that their child may develop bronchiolitis,” he added. Andalusia to administer anti-RSV monoclonal antibodies for the first time – called Nirsevimab, trade name Beyfortus –.In this way, the autonomous community continues Bet on prevention In terms of health, and One of the most advanced vaccination programs in the country.
Along these lines, he emphasized This measure is added to the annual flu vaccination Population of children aged 6 months to 5 years (59 months), the campaign is launched in Andalusia during the 2022-2023 campaign, “Aims to protect children as much as possible from the most common respiratory diseases and give them as much care as possible”. In the first year of childhood vaccination, more than 45% of the target population has been reached.
On the other hand, he pointed out that the General Administration of Public Health and Drug Administration has RSV Acute Respiratory Infection Sentinel Surveillance Programwhether primary care or hospital care, thereby joining Joint Covid19/influenza surveillance strategy for the 2020-2021 season.